234 related articles for article (PubMed ID: 9673375)
21. [Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion].
Munker R; Darsow M; Stötzer O; Kremer JP; Mezger J
Med Klin (Munich); 1994 May; 89(5):248-51. PubMed ID: 8052178
[TBL] [Abstract][Full Text] [Related]
22. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
Moritani Y
Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB; Gheith SM
Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
[TBL] [Abstract][Full Text] [Related]
24. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma.
Hyakudomi M; Matsubara T; Hyakudomi R; Yamamoto T; Kinugasa S; Yamanoi A; Maruyama R; Tanaka T
Ann Surg Oncol; 2008 Jun; 15(6):1775-82. PubMed ID: 18363071
[TBL] [Abstract][Full Text] [Related]
26. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
27. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
28. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
29. [Immune status of the spleen and surgical treatment in patients with advanced gastric cancer].
Zhu Z
Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):330-3, 381. PubMed ID: 1332809
[TBL] [Abstract][Full Text] [Related]
30. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
31. The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta.
Noma K; Yamaguchi Y; Okita R; Matsuura K; Toge T
Anticancer Res; 2005; 25(1B):643-9. PubMed ID: 15816640
[TBL] [Abstract][Full Text] [Related]
32. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
34. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
[TBL] [Abstract][Full Text] [Related]
35. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
36. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
37. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
38. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
39. Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract.
Aparicio-Pagés MN; Verspaget HW; Peña AS; Lamers CB
J Clin Lab Immunol; 1991 May; 35(1):27-32. PubMed ID: 1668287
[TBL] [Abstract][Full Text] [Related]
40. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]